An SSDP & MAPS Benefit Event, on the Night of the FDA Public Hearing

The psychedelic community is coming to DC for a major FDA public hearing on the therapeutic use of psychedelics—bringing together federal officials, researchers, clinicians, patients, and movement leaders. When the hearing ends, THE GATEWAY opens.

Join the people shaping the future of psychedelics for an intimate evening of sensemaking, connection, food, drinks, and a live podcast recording while the conversations from the day are still fresh.

TICKETS: https://secure.everyaction.com/z6Pd9tpUSkSUA1I20B214g2

This is where researchers meet advocates, policymakers meet practitioners, industry meets movement leaders — and the people who spent the day talking to the FDA finally get to talk to each other.

THE GATEWAY is the place to find the others — the people asking the same questions, fighting the same fights, building the weird new things, and imagining where psychedelics could go from here.

Come straight from the FDA hearing. Grab a drink. Compare notes. Meet someone you've only known from the internet. Find your next collaborator. Have the conversation that couldn't happen at the microphone.

Then we bring the room together for the question everyone will be asking:

What comes next?

To close the night, THE GATEWAY goes live. Betty Aldworth of MAPS, Kat Murti of SSDP, Meredith Thomas of Thank You Life, Simeon Schnapper of JLS Fund, Brigitte Gordon, DNP, PMHNP-BC of Journey Clinical, and Samantha Juan, veteran and advocate, join The Gateway hosts Joe Moore of Psychedelics Today, Anne Philippi of The New Health Club, and Marissa Feinberg of PSYCA and Triple Bottom Why for a live podcast recording unpacking what happened at FDA — and where psychedelics go from here.

What did we learn? What is changing? What does this mean for people waiting for access? What could accelerate progress — or derail it? And who gets to shape the next era of psychedelics?

Expect a candid conversation spanning science, policy, regulation, access, mental health, culture, business, and the movement itself — recorded live to close out the evening.

The story doesn't end at FDA.

This hearing lands at a remarkable moment for psychedelics: new FDA guidance for psychedelic clinical investigations, federal attention to psilocybin and methylone programs, and an Executive Order directing the government to accelerate treatments for serious mental illness. The trade press will cover the hearing. The wires will file their stories. THE GATEWAY takes the story out of the hearing room that same night — bringing together the people doing the work to ask what the day's developments actually mean for Americans waiting on approved access, and what we do next.

Your $20 ticket includes heavy apps, one drink, the networking reception, and the live recording. And because ticket sales benefit SSDP and MAPS, just by showing up, you're helping fuel the psychedelic renaissance. SSDP Ambassadors get in free.

The FDA hearing may shape what comes next for psychedelics. So will the people in this room. Find the others at THE GATEWAY.

Space is limited. The window is short. Get on the list.

TICKETS: https://secure.everyaction.com/z6Pd9tpUSkSUA1I20B214g2